Xavier Matías‐Guiu

30.6k total citations · 7 hit papers
435 papers, 16.1k citations indexed

About

Xavier Matías‐Guiu is a scholar working on Molecular Biology, Oncology and Reproductive Medicine. According to data from OpenAlex, Xavier Matías‐Guiu has authored 435 papers receiving a total of 16.1k indexed citations (citations by other indexed papers that have themselves been cited), including 157 papers in Molecular Biology, 119 papers in Oncology and 96 papers in Reproductive Medicine. Recurrent topics in Xavier Matías‐Guiu's work include Ovarian cancer diagnosis and treatment (86 papers), Endometrial and Cervical Cancer Treatments (79 papers) and Genetic factors in colorectal cancer (46 papers). Xavier Matías‐Guiu is often cited by papers focused on Ovarian cancer diagnosis and treatment (86 papers), Endometrial and Cervical Cancer Treatments (79 papers) and Genetic factors in colorectal cancer (46 papers). Xavier Matías‐Guiu collaborates with scholars based in Spain, United States and United Kingdom. Xavier Matías‐Guiu's co-authors include Jaime Prat, Xavier Dolcet, David Llobet‐Navàs, Judit Pallarés, Lluís Catasús, Elena Bussaglia, Sónia Gatius, Marı́a Santacana, José Palacios and Gema Moreno‐Bueno and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Xavier Matías‐Guiu

416 papers receiving 15.8k citations

Hit Papers

NF-kB in development and progression of human cancer 2005 2026 2012 2019 2005 2007 2023 2020 2019 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. NF-kB in development and progression of human cancer
    2005 910 citations Xavier Dolcet, Xavier Matías‐Guiu et al. profile →
  2. Expression of p95HER2, a Truncated Form of the HER2 Receptor, and Response to Anti-HER2 Therapies in Breast Cancer
    2007 659 citations Maurizio Scaltriti, Federico Rojo et al. JNCI Journal of the National Cancer Institute profile →
  3. FIGO staging of endometrial cancer: 2023
    2023 412 citations Xavier Matías‐Guiu, Carien L. Creutzberg et al. profile →
  4. ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer
    2020 261 citations Xavier Matías‐Guiu et al. profile →
  5. Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas
    2019 255 citations Remi A. Nout, Joseph W. Carlson et al. profile →
  6. Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups
    2018 253 citations Tjalling Bosse, Remi A. Nout et al. profile →
  7. FIGO staging of endometrial cancer: 2023
    2023 112 citations Xavier Matías‐Guiu, Carien L. Creutzberg et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xavier Matías‐Guiu Spain 64 6.4k 4.2k 4.1k 3.8k 3.5k 435 16.1k
Russell R. Broaddus United States 69 5.8k 0.9× 4.9k 1.2× 3.6k 0.9× 3.4k 0.9× 4.4k 1.2× 286 15.1k
Beth Y. Karlan United States 69 8.0k 1.3× 6.4k 1.5× 2.0k 0.5× 6.6k 1.7× 3.9k 1.1× 336 18.9k
C. Blake Gilks Canada 63 4.2k 0.7× 5.0k 1.2× 3.3k 0.8× 4.6k 1.2× 3.5k 1.0× 179 14.3k
Christian Marth Austria 61 5.8k 0.9× 5.3k 1.3× 2.2k 0.5× 3.1k 0.8× 2.8k 0.8× 411 14.0k
Harry Hollema Netherlands 61 3.5k 0.5× 4.0k 1.0× 2.3k 0.6× 1.8k 0.5× 2.3k 0.7× 229 11.9k
Lauri A. Aaltonen Finland 75 8.3k 1.3× 10.0k 2.4× 1.7k 0.4× 1.7k 0.4× 6.5k 1.8× 284 22.9k
Rainer Kimmig Germany 52 2.2k 0.4× 3.6k 0.9× 1.8k 0.4× 3.6k 1.0× 2.3k 0.7× 402 10.3k
Daisuke Aoki Japan 47 3.6k 0.6× 2.5k 0.6× 3.5k 0.8× 3.6k 1.0× 2.0k 0.6× 440 11.0k
Kathleen R. Cho United States 66 10.5k 1.7× 6.3k 1.5× 1.1k 0.3× 2.4k 0.6× 4.8k 1.4× 152 18.8k
Robert A. Soslow United States 85 4.8k 0.8× 4.3k 1.0× 11.2k 2.7× 10.4k 2.7× 3.7k 1.0× 426 23.6k

Countries citing papers authored by Xavier Matías‐Guiu

Since Specialization
Citations

This map shows the geographic impact of Xavier Matías‐Guiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Matías‐Guiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Matías‐Guiu more than expected).

Fields of papers citing papers by Xavier Matías‐Guiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Matías‐Guiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Matías‐Guiu. The network helps show where Xavier Matías‐Guiu may publish in the future.

Co-authorship network of co-authors of Xavier Matías‐Guiu

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Matías‐Guiu. A scholar is included among the top collaborators of Xavier Matías‐Guiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Matías‐Guiu. Xavier Matías‐Guiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Figueras, Albert, Elisenda Alsina‐Sanchís, August Vidal, et al.. (2023). Ovarian cancer relies on the PDGFRβ –fibronectin axis for tumorsphere formation and metastatic spread. Molecular Oncology. 18(1). 136–155. 7 indexed citations
2.
Cartón‐García, Fernando, Higinio Dopeso, Irati Macaya, et al.. (2022). Myosin Vb as a tumor suppressor gene in intestinal cancer. Oncogene. 41(49). 5279–5288. 2 indexed citations
3.
García‐Mulero, Sandra, et al.. (2022). Facts and Hopes in Immunotherapy of Endometrial Cancer. Clinical Cancer Research. 28(22). 4849–4860. 35 indexed citations
4.
Palomero, Jara, Ana Vivancos, Carlos E. de Andrea, et al.. (2022). Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer.. Journal for ImmunoTherapy of Cancer. 10(12). e005443–e005443. 36 indexed citations
5.
Peremiquel‐Trillas, Paula, Laia Alemany, Alberto Ameijide, et al.. (2022). Predicting Ovarian-Cancer Burden in Catalonia by 2030: An Age–Period–Cohort Modelling. International Journal of Environmental Research and Public Health. 19(3). 1404–1404. 7 indexed citations
6.
Benavente, Yolanda, Jordi Ponce, Joan Brunet, et al.. (2020). Sensitivity of cervico‐vaginal cytology in endometrial carcinoma: A systematic review and meta‐analysis. Cancer Cytopathology. 128(11). 792–802. 32 indexed citations
7.
Murali, Ramachandran, Ben Davidson, Oluwole Fadare, et al.. (2018). High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations. International Journal of Gynecological Pathology. 38(Supplement 1). S40–S63. 175 indexed citations
8.
Depreeuw, Jeroen, Ellen Stelloo, Elisabeth M. Osse, et al.. (2017). Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma. Clinical Cancer Research. 23(23). 7232–7241. 35 indexed citations
9.
Martínez-García, Elena, Antoine Lesur, Laura Devis, et al.. (2017). Targeted Proteomics Identifies Proteomic Signatures in Liquid Biopsies of the Endometrium to Diagnose Endometrial Cancer and Assist in the Prediction of the Optimal Surgical Treatment. Clinical Cancer Research. 23(21). 6458–6467. 50 indexed citations
10.
Figueras, Albert, Elisenda Alsina‐Sanchís, Laura Muinelo‐Romay, et al.. (2017). A Role for CXCR4 in Peritoneal and Hematogenous Ovarian Cancer Dissemination. Molecular Cancer Therapeutics. 17(2). 532–543. 28 indexed citations
11.
Mančíková, Veronika, Cristina Montero‐Conde, Javier Perales-Patón, et al.. (2016). Multilayer OMIC Data in Medullary Thyroid Carcinoma Identifies the STAT3 Pathway as a Potential Therapeutic Target in RET M918T Tumors. Clinical Cancer Research. 23(5). 1334–1345. 20 indexed citations
12.
Pedrola, Núria, Laura Devis, Irene Campoy, et al.. (2015). Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion. Clinical & Experimental Metastasis. 32(5). 467–478. 48 indexed citations
13.
Eritja, Núria, Cristina Mirantes, Marı́a Santacana, et al.. (2014). Combinatorial Therapy Using Dovitinib and ICI182.780 (Fulvestrant) Blocks Tumoral Activity of Endometrial Cancer Cells. Molecular Cancer Therapeutics. 13(4). 776–787. 11 indexed citations
14.
Urdinguio, Rocío G., Agustín F. Fernández, Ángela Moncada-Pazos, et al.. (2012). Immune-Dependent and Independent Antitumor Activity of GM-CSF Aberrantly Expressed by Mouse and Human Colorectal Tumors. Cancer Research. 73(1). 395–405. 65 indexed citations
15.
Scaltriti, Maurizio, Federico Rojo, Alberto Ocaña, et al.. (2007). Expression of p95HER2, a Truncated Form of the HER2 Receptor, and Response to Anti-HER2 Therapies in Breast Cancer. JNCI Journal of the National Cancer Institute. 99(8). 628–638. 659 indexed citations breakdown →
16.
Domingo, Pere, Xavier Matías‐Guiu, Ramón M. Pujol, et al.. (1999). Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy. AIDS. 13(16). 2261–2267. 177 indexed citations
17.
Catasús, Lluís, Pilar Fernández Machín, Xavier Matías‐Guiu, & Jaime Prat. (1998). Microsatellite instability in endometrial carcinomas: clinicopathologic correlations in a series of 42 cases. Human Pathology. 29(10). 1160–1164. 130 indexed citations
18.
Capellá, Gabriel, et al.. (1996). Ras Oncogene Mutations in Thyroid Tumors. Diagnostic Molecular Pathology. 5(1). 45–52. 49 indexed citations
19.
Prat, Jaime, Esther Oliva, Enrique Lerma, Manuel Vaquero, & Xavier Matías‐Guiu. (1994). Uterine papillary serous adenocarcinoma. A 10-case study of p53 and c-erbB-2 expression and DNA content. Cancer. 74(6). 1778–1783. 56 indexed citations
20.
Matías‐Guiu, Xavier, et al.. (1990). Cavernous angiomas of the cranial nerves. Journal of neurosurgery. 73(4). 620–622. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Russell R. Broaddus Breakdown of academic impact, for papers by Beth Y. Karlan Breakdown of academic impact, for papers by C. Blake Gilks Breakdown of academic impact, for papers by Christian Marth Breakdown of academic impact, for papers by Harry Hollema Breakdown of academic impact, for papers by Lauri A. Aaltonen Breakdown of academic impact, for papers by Rainer Kimmig Breakdown of academic impact, for papers by Daisuke Aoki Breakdown of academic impact, for papers by Kathleen R. Cho Breakdown of academic impact, for papers by Robert A. Soslow
Rankless by CCL
2026